Genetic Variation For Enzyme In Lung May Point To Cancer Susceptibility Gene, Mechanisms That May Cause Cancer

November 19, 1997

A preliminary study by scientists at the National Institute of Environmental Health Sciences indicates that a human gene variation that reduces production of an enzyme in the lungs also makes people less susceptible to lung cancer.

The scientists said about 8 percent of the population -- 9.4 percent of African Americans and 7.8 percent of Caucasians--have the "protective" gene form, or polymorphism, which reduces by about 54 percent the risk of a smoker getting lung cancer. Called the myeloperoxidase gene, the protective form of it is designated A/A. Most people have the A/G or G/G forms of the gene which confer no protection against lung cancer. Only about 5%, or 16 out of 339, of people in the study with lung cancer had the protective gene, but about 8%, 59 out of 703, of controls had it.

NIEHS' Stephanie J. London, M.D., Dr.P.H., and Jack A. Taylor, M.D., and BioServe Biotechnologies' Terri A. Lehman, reported today in Cancer Research that they collected blood samples from lung cancer patients and randomly collected non-patient controls from Los Angeles County, Calif., which were then compared for the presence of genotype A/A.

The significance of the presence or absence of genotype A/A, and its consequences for a person's chances of developing lung cancer, is related to the enzyme which is produced by everyone but reduced in people with genotype A/A.

"The enzyme, myeloperoxidase, activates the potent carcinogen benzo(a)pyrene, which is a product of tobacco smoke, the burning of most fuels and most other kinds of combustion," Dr. London said.

She said the enzyme may also lead to lung cancer by generating free radicals which are molecules that disrupt the copying of genes and cause genetic errors that can lead to cancer.

"This is a preliminary study; it requires confirmation in other data. If confirmed these potential mechanisms will have to be studied more fully," Dr. London said. "Myeloperoxidase is of interest -- there is a lot of it in the lungs of smokers and it is good at activating tobacco carcinogens into their more dangerous forms."

NIH/National Institute of Environmental Health Sciences

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to